Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waisman Biomanufacturing has manufactured over 300 clinical-grade products since its founding in 2001. It specializes in cGMP production of biologics—including cell therapies, gene therapies, vaccines, recombinant proteins—for use in human clinical trials. The company does not develop its own therapeutics but provides end-to-end process development and manufacturing services to biotech companies and academic groups globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waisman Biomanufacturing.